Seguir
Mary Gulumian
Mary Gulumian
National Institute for Occupational Health
Dirección de correo verificada de nioh.nhls.ac.za
Título
Citado por
Citado por
Año
Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases
A Shukla, M Gulumian, TK Hei, D Kamp, Q Rahman, BT Mossman
Free Radical Biology and Medicine 34 (9), 1117-1129, 2003
3262003
Dissolution and biodurability: Important parameters needed for risk assessment of nanomaterials
W Utembe, K Potgieter, AB Stefaniak, M Gulumian
Particle and fibre toxicology 12, 1-12, 2015
2042015
Particle toxicology and health-where are we?
M Riediker, D Zink, W Kreyling, G Oberdörster, A Elder, U Graham, ...
Particle and fibre toxicology 16, 1-33, 2019
2032019
Mechanistically identified suitable biomarkers of exposure, effect, and susceptibility for silicosis and coal-worker's pneumoconiosis: a comprehensive review
M Gulumian, PJA Borm, V Vallyathan, V Castranova, K Donaldson, ...
Journal of Toxicology and Environmental Health, Part B 9 (5), 357-395, 2006
1872006
Challenges facing sterilization and depyrogenation of nanoparticles: Effects on structural stability and biomedical applications
MA Vetten, CS Yah, T Singh, M Gulumian
Nanomedicine: Nanotechnology, Biology and Medicine 10 (7), 1391-1399, 2014
1492014
Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis
V Steenkamp, MC Gouws, M Gulumian, EE Elgorashi, J Van Staden
Journal of Ethnopharmacology 103 (1), 71-75, 2006
1482006
The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles
K Donaldson, PJA Borm, V Castranova, M Gulumian
Particle and fibre toxicology 6, 1-8, 2009
1412009
Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell lines
MA Vetten, N Tlotleng, D Tanner Rascher, A Skepu, FK Keter, K Boodhia, ...
Particle and fibre toxicology 10, 1-15, 2013
1362013
NanoSolveIT Project: Driving nanoinformatics research to develop innovative and integrated tools for in silico nanosafety assessment
A Afantitis, G Melagraki, P Isigonis, A Tsoumanis, DD Varsou, ...
Computational and Structural Biotechnology Journal 18, 583-602, 2020
942020
Size-dependent clearance of gold nanoparticles from lungs of Sprague–Dawley rats after short-term inhalation exposure
SG Han, JS Lee, K Ahn, YS Kim, JK Kim, JH Lee, JH Shin, KS Jeon, ...
Archives of toxicology 89, 1083-1094, 2015
902015
Risk assessment of benzene, toluene, ethyl benzene, and xylene concentrations from the combustion of coal in a controlled laboratory environment
MD Masekameni, R Moolla, M Gulumian, D Brouwer
International journal of environmental research and public health 16 (1), 95, 2019
832019
Hazards identified and the need for health risk assessment in the South African mining industry
W Utembe, EM Faustman, P Matatiele, M Gulumian
Human & experimental toxicology 34 (12), 1212-1221, 2015
782015
From the Cover: An Investigation of the Genotoxicity and Interference of Gold Nanoparticles in Commonly Used In Vitro Mutagenicity and Genotoxicity Assays
JM George, M Magogotya, MA Vetten, AV Buys, M Gulumian
Toxicological Sciences 156 (1), 149-166, 2017
682017
Toward rigorous materials production: new approach methodologies have extensive potential to improve current safety assessment practices
P Nymark, M Bakker, S Dekkers, R Franken, W Fransman, ...
Small 16 (6), 1904749, 2020
562020
Antioxidant and genotoxic properties of South African herbal extracts
V Steenkamp, H Grimmer, M Semano, M Gulumian
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 581 (1-2 …, 2005
552005
Cytotoxicity, intracellular localization and exocytosis of citrate capped and PEG functionalized gold nanoparticles in human hepatocyte and kidney cells
N Tlotleng, MA Vetten, FK Keter, A Skepu, R Tshikhudo, M Gulumian
Cell biology and toxicology 32, 305-321, 2016
532016
The role of oxidative stress in diseases caused by mineral dusts and fibres: current status and future of prophylaxis and treatment
M Gulumian
Stress Adaptation, Prophylaxis and Treatment, 69-77, 1999
501999
Transcriptomics in toxicogenomics, part I: experimental design, technologies, publicly available data, and regulatory aspects
PAS Kinaret, A Serra, A Federico, P Kohonen, P Nymark, I Liampa, MK Ha, ...
Nanomaterials 10 (4), 750, 2020
492020
Transcriptomics in toxicogenomics, part III: data modelling for risk assessment
A Serra, M Fratello, L Cattelani, I Liampa, G Melagraki, P Kohonen, ...
Nanomaterials 10 (4), 708, 2020
462020
Introducing a new standardized nanomaterial environmental toxicity screening testing procedure, ISO/TS 20787: aquatic toxicity assessment of manufactured nanomaterials in …
SA Johari, K Rasmussen, M Gulumian, M Ghazi-Khansari, N Tetarazako, ...
Toxicology Mechanisms and Methods 29 (2), 95-109, 2019
432019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20